REFERENCES
- Mariotti S. New steps toward eliminating blinding trachoma. N Engl J Med 2004; 19(351)2004–2007, [CSA]
- Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bulletin of the World Health Organization 2004; 82(11)844–852, [INFOTRIEVE], [CSA]
- Pruss A, Mariotti S. Preventing trachoma through environmental sanitation: A review of the evidence base. Bulletin of the World Health Organization 2000; 78(2)258–266, [INFOTRIEVE], [CSA]
- Bailey R, Lietman T. The SAFE strategy for the elimination of trachoma by 2020: Will it work?. Bulletin of the World Health Organization 2001; 79(3)233–236, [INFOTRIEVE], [CSA]
- Leitman T. Trachoma control: the end of the beginning?. Ophthalmology 2001; 108(12)2163–2164, [CSA], [CROSSREF]
- Mabey D, Solomon A, Foster A. Trachoma. Lancet 2003; 362: 223–229, [INFOTRIEVE], [CSA], [CROSSREF]
- Bowman R, Jatta B, Cham B, et al. Natural history of trachomaatous scarring in the Gambia. Ophthalmology 2001; 108(12)2219–2224, [INFOTRIEVE], [CSA], [CROSSREF]
- World Health Organization. Global inniative for the elimination of avoidable blindness. Geneva 1997, WHO/PBL/97.61
- Tabbara K, Abu-el-Asar A, Al-Omar O, Choudhury A H, al-Faisal Z. Single-dose azithromycin in the treatment of trachoma. Ophthalmology 1996; 103: 842–846, [INFOTRIEVE], [CSA]
- 2002, Kariba Dam: Zambia and Zimbabwe. Cape Town, South Africa: World Commission on Dams
- Thylefors B, Dawson C, Jones B. A simple system for the assessment of trachoma and its complications. Bulletin of the World Health Organization 1987; 65: 477–483, [INFOTRIEVE], [CSA]
- Angell M. The ethics of clinical research in the third world. N Engl J Med 1997; 337(12)847–849, [INFOTRIEVE], [CSA], [CROSSREF]
- Stenberg K, Mardh P. Treatment of concomitant eye and genital chlamydial infection with erythromycin and roxithromycin. Acta Ophthalmol 1993; 71(3)332–335, [CSA]
- Emerson P, Lindsay S, Alexander N, et al. Role of flies and provision of latrines in trachoma control: cluster-randomised controlled trial. Lancet 2004; 363: 1093–1098, [INFOTRIEVE], [CSA], [CROSSREF]
- Frick K, Basilion E, Hanson C, Colchero M A. Estimating the burden and economic impact of trachomatous visual loss. Ophthalmic Epidemiology 2003; 10(2)121–132, [INFOTRIEVE], [CSA], [CROSSREF]
- Belmekki M. Pit latrines for trachoma control. Lancet 2004; 363: 1088–1089, [INFOTRIEVE], [CSA], [CROSSREF]
- Moalic E, Dueymes J, Baron R, Flohic A L. Cross-sectional survey of trachoma in school age children in the region of Thies (Senegal). Pediatr Infect Dis 2000; 19(10)979–983, [CSA]
- Taylor H, West S, Mmbaga B, et al. Hygiene factors and increased risk of trachoma in central Tanzania. Arch Ophthalmol. 1989; 107: 1821–1825, [INFOTRIEVE], [CSA]
- West S, Lynch M, Turner V, et al. Water availability and Trachoma. Bulletin of the World Health Organization 1989; 67: 71–75, [INFOTRIEVE], [CSA]
- Solomon A, Holland M, Burton M, et al. Strategies for control of trachoma: observational study with quantitative PCR. Lancet. 2003; 362: 198–204, [INFOTRIEVE], [CSA], [CROSSREF]
- Hseih Y, Bobo L, Quinn T, West S. Risk factors for Trachoma: 6-year follow-up of children aged 1 and 2 years. Am J Epidemiology 2000; 152(3)204–211, [CSA], [CROSSREF]
- Mabey D, Holland M, Solomon A. The Epidemiology of Ocular Chlamydia Trachomatis Infection in a Trachoma Endemic Community Determined by Quantitative PCR. 10th international symposium on human chlamydial infections, AntalyaTurkey, 2002
- Lynch M, West S, Munoz B, et al. Azithromycin treatment coverage in Tanzanian children using community volunteers. Ophthal Epidemiol 2003; 10(3)167–175, [CSA], [CROSSREF]
- Bowman R, Sillah A. Dehn Cv, et al. Operational comparison of single-dose Azithromycin and Topical Tetracycline for Trachoma. Invest Ophthalmol Vis Sci 2000; 41(13)4074–4079, [INFOTRIEVE], [CSA]
- Schachter J. Azithromycin in control of trachoma. Lancet 1999; 354: 630–635, [INFOTRIEVE], [CSA], [CROSSREF]
- Dawson C. A comparison of oral azithromycin with topical oxytetracycline/polymixin for the treatment of trachoma in children. Clinical Infectious Diseases 1997; 24: 363–368, [INFOTRIEVE], [CSA]
- Bailey R. Randomised controlled trial of single-dose azithromycin in treatment of trachoma. Lancet 1993; 342: 453–456, [INFOTRIEVE], [CSA], [CROSSREF]
- Solomon A, Akudibillah J, Abugri P, et al. Pilot study of the use of community volunteers to distribute azithromycin for trachoma control in Ghana. Bulletin of the World Health Organization 2001; 79(1)8–14, [INFOTRIEVE], [CSA]
- Solomon A, Holland M, Alexander N, et al. Mass treatment with single-dose Azithromycin for trachoma. N Engl J Med 2004; 351(19)1962–1971, [INFOTRIEVE], [CSA], [CROSSREF]
- Markham A, Faulds D. Roxithromycin. An update of its antimicrobial activity, pharmacokinetic properties and therapeutic use. Drugs 1994; 48(2)297–326, [INFOTRIEVE], [CSA]
- Emerson P, Bailey R, Walraven G, Lindsay S. Human and other faeces as breeding media of the trachoma vector Musca sorbens. Med Vet Entomol 2001; 15: 314–320, [INFOTRIEVE], [CSA], [CROSSREF]
- Johnson G. The environment and the eye. 1–16, Eye 2004;advance online publication, 26 march
- Miller K, Pakpour N, Yi E, et al. Pesky tachoma suspect finally caught. British Journal of Ophthalmology 2004; 88: 750–751, [INFOTRIEVE], [CSA], [CROSSREF]
- Reacher M, Munoz B, Alghassany A. A controlled trial of surgery for trachomatous trichiasis of the upper lid. Arch Ophthalmol 1992; 110: 667–674, [INFOTRIEVE], [CSA]